Cory Jubinville
Stock Analyst at LifeSci Capital
(1.90)
# 3,002
Out of 4,870 analysts
3
Total ratings
50%
Success rate
6.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cory Jubinville
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERV Verve Therapeutics | Downgrades: Market Perform | $12 | $11.11 | +8.01% | 1 | Jun 18, 2025 | |
| MREO Mereo BioPharma Group | Initiates: Outperform | $10 | $2.74 | +264.96% | 1 | Dec 24, 2024 | |
| LQDA Liquidia | Initiates: Outperform | $30 | $13.26 | +126.24% | 1 | Oct 3, 2024 |
Verve Therapeutics
Jun 18, 2025
Downgrades: Market Perform
Price Target: $12
Current: $11.11
Upside: +8.01%
Mereo BioPharma Group
Dec 24, 2024
Initiates: Outperform
Price Target: $10
Current: $2.74
Upside: +264.96%
Liquidia
Oct 3, 2024
Initiates: Outperform
Price Target: $30
Current: $13.26
Upside: +126.24%